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Abstract 
Microscopic polyangiitis is a small-
vessel vasculitis which results in pauci-
immune necrotizing inflammation of blood 
vessel walls. In this report, we describe a 
case of microscopic polyangiitis in a 65-year 
old female who presented with a one month 
history of lower back pain followed by 
reduced appetite, weight loss and fever. An 
immunology screen detected perinuclear 
anti-neutrophil cytoplasmic antibodies with 
myeloperoxidase specificity in the serum. A 
renal biopsy was obtained because of mild 
proteinuria on urinalysis and revealed a small 
vessel vasculitis consistent with microscopic 
polyangiitis. She was started on treatment 
with glucocorticoids and cyclophosphamide 
which resulted in a positive clinical response, 
with resolution of fever and improvement in 
her inflammatory markers. Currently she is 
stable and since starting treatment, she has 
not had any relapses or flare ups. 
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Introduction  
 Microscopic polyangiitis (MPA) is a rare 
condition associated with a significant burden of 
disease. Its non-specific presentation can represent a 
diagnostic challenge and lead to a delay in initiation 
of treatment. We report the case of a patient with 
MPA as an important clinical reminder to maintain 
a high index of suspicion in patients with persistent 
fever.  
 
Case presentation   
 A 65-year old lady presented with a one month 
history of worsening exertional low back pain 
radiating to both lower limbs. There was no 
nocturnal pain or sphincter dysfunction. A Doppler 
Ultrasound of both lower limbs ruled out deep 
venous thrombosis and a Lumbosacral spine X-ray 
showed degenerative disc disease. The patient was 
diagnosed with mechanical back pain and 
discharged home on analgesia. 
She presented again ten days later, with 
persistent low back pain together with myalgias in 
both of her calves. This time the pain was 
associated with reduced appetite and 2kg weight 
loss. She also had an on-going fever of up to 
38.2
O
C present since seven days.  
She was otherwise hemodynamically stable 
and her physical examination was unremarkable. 
She had no rashes, no arthritis, no localised 
tenderness or focal neurological deficits.   
Her past medical history included 
gastroesophageal reflux disease and 
hypothyroidism. She had no significant travel, 
social and family history.  
 
Investigations  
Initial investigations revealed a raised White 
cell count (22.66x10
9
/L), Erythrocyte sediment rate 
(112mm1stHr) and C-reactive protein (125.9mg/L) 
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in-keeping with a marked inflammatory response. 
Haemoglobin was low (8.9g/dL) and haematinics 
showed low iron and folate stores. Urinalysis 
confirmed the presence of protein (25mg/dL) and 
erythrocytes (25mg/dL).  
Infection was the primary suspected diagnosis. 
A Chest radiograph was taken and specimens of 
blood, urine and sputum were obtained and 
analysed for culture and sensitivity. Following this, 
the patient was started on empirical treatment with 
intravenous antibiotics.  
However, the fever persisted and inflammatory 
markers remained elevated. A Computed 
Tomography scan of the Thorax, Abdomen and 
Pelvis was performed to assess for occult infection 
including abscess formation or malignancy. The 
scan was grossly normal except for mild thickening 
of the gastroesophageal junction. Malignancy was 
ruled out after a gastroscopy was normal. A 
transthoracic echocardiogram was also performed 
which did not reveal any vegetations. 
Due to a progressive anaemia and persistent 
leucocytosis and thrombocytosis a diagnosis of 
myelodysplasia was considered. However, JAK2-
V617F and BCR-ABL mutations were negative 
and a blood film showed only reactive-looking 
features. No monoclonal bands were detected on 
serum protein electrophoresis either. 
On immunology screen, a high-titre of 
Myeloperoxidase-anti-neutrophil cytoplasmic 
antibodies (MPO-ANCA) (199.7U/mL) was 
detected, whilst other components of the 
immunology screen including Extractable nuclear 
antigen, Anti-nuclear antibody, Complement, 
Aldolase and Creatine kinase were normal. A viral 
screen was also negative.  
In view of the history of proteinuria, a renal 
biopsy was obtained which confirmed the presence 
of a pauci-immune necrotizing small-vessel 
vasculitis. A total of twenty-five glomeruli were 
sampled and examined under light and electron 
microscopy (Figure 1 and 2). Indirect 
immunofluorescence was also used which 
demonstrated weak IgM-staining in mesangial 
areas whilst IgG, IgA and C3 were negative.  
Figure 1: Light microscopy of renal biopsy specimen 
Light microscopy of renal biopsy specimen which shows histopathological evidence of transmural 
fibrinoid necrosis of a small artery with sparing of glomerulus (Haematoxylin & eosin stain). 
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Figure 2: Electron microscopy of renal biopsy specimen 
Electron microscopy of renal biopsy specimen which shows mild endothelial swelling and loss of 
fenestrations. The basement membrane and podocyte layer are normal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment and Outcome  
She received three pulses of intravenous 
methylprednisolone 500mg daily followed by a 
course of oral prednisolone at an initial dose of 
1mg/kilogram/day (patient weighed 46kg) with 
good clinical effect. She was discharged on a 
tapering dose regime of oral prednisolone with 
calcium and vitamin D supplementation. She also 
underwent a Dual-energy X-ray absorptiometry 
scan with a view to starting bisphosphonate 
treatment after dental review and clearance.  
Following education and counselling, she 
received intravenous cyclophosphamide (CP) with 
prophylactic co-trimoxazole and mercaptoethane 
sulfonate.  
Since her diagnosis about one month ago, she 
is currently tailing off her steroids and undergoing 
treatment with 600mg of CP for a total of six 
doses. 
 
Discussion  
MPA is a MPO-ANCA-positive 
vasculitis which causes a pauci-immune 
necrotising inflammation of predominantly 
small blood vessels.
1
 
 The incidence of MPA in Europe ranges from 
2.4 to 10.1 per million, whilst the prevalence ranges 
from 25.1 to 94 per million
 
and shows an increase 
with age.
2 
 
MPA mainly presents with non-specific 
symptoms such as fever, myalgia, anorexia, weight 
loss and night sweats.
3
 Therefore tissue-biopsy 
evidence of vasculitis is the gold standard for 
diagnosis.  
  
MPA has the capacity to affect any organ but 
it has a predilection for the kidneys and lungs.
3
 
Renal manifestations include haematuria, 
proteinuria, red cell casts and focal segmental 
rapidly progressive glomerulonephritis.
3 
The latter 
condition is life-threatening and leads to a rapid 
deterioration in glomerular filtration rate of at least 
50% over weeks or days and extensive glomerular 
crescent formation.
3 
Renal involvement in ANCA-
associated vasculitis (AAV) has a worse prognosis 
in MPO-ANCA patients and glomerular sclerosis is 
associated with worse outcomes.
4-5  
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The most important pulmonary manifestation 
of MPA is alveolar haemorrhage which occurs in 
about a third of MPA patients and it can be severe 
and life-threatening.
3 
 
New-onset organ-threatening or life-
threatening disease is treated with glucocorticoids 
in combination with CP or rituximab (RX) which 
have similar efficacy profiles in induction of 
disease remission.
6 
Pulse intravenous CP is 
preferred to daily oral CP as it results in a lower 
cumulative dose and is associated with less side-
effects.
7  
 
Non-organ-threatening disease is treated with 
glucocorticoids in combination with methotrexate 
(MTX) or mycophenolate mofetil (MMF) whilst 
plasma exchange is reserved for patients with 
rapidly progressive renal failure or severe 
pulmonary haemorrhage.
6
 
   
 
Disease remission should be maintained with a 
combination of low-dose glucocorticoids and 
immunosuppressive therapy
 
which include 
azathioprine (AZA), RX, MTX and MMF.
6 
The 
glucocorticoid-immunosuppressive treatment 
should be continued for a minimum length of 24 
months and early cessation increases risk of 
relapse.
6  
 
 AAV demonstrate a 2.7-fold increased 
mortality risk compared with the general 
population.
8 
MPA long-term prognosis is less 
severe but relapses are frequent and can occur 
years after initial diagnosis.
9
 The main factors 
affecting survival are age, renal involvement and 
burden of treatment.
9
 Early diagnosis, treatment 
and prolonged follow-up are crucial to overcome 
the pitfalls related to MPA and improve patient 
outcomes.  
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